Drug accelerator Cydan is hiring on Yongchang Qiu, Ph.D., as vice president of preclinical development and Ryan Tyler, Ph.D., as senior director of preclinical research.
The biotech builders at Cydan Development have launched their second rare-disease venture, gathering a $31 million cash cache from a group of A-list backers that includes Pfizer and New Enterprise Associates.